Searchable abstracts of presentations at key conferences in endocrinology

ea0092ps2-13-06 | Surgery | ETA2023

Prospective implementation of thyroid lobectomy recommendations and thyrospec molecular testing for bethesda III and IV nodules and impact on surgery

Yeo Caitlin , Wu Jiahui , Stewardson Paul , Eszlinger Markus , Paschke Ralf

Objectives: In May 2016, the local thyroid cancer tumor group proposed and adopted specific thyroid lobectomy recommendations based on the 2015 ATA guidelines. ThyroSPEC molecular testing was introduced for all Bethesda III and IV lesions in August 2020. The goal of this study was to evaluate the implementation of the ATA lobectomy guidelines and the introduction of ThyroSPEC molecular testing on rates of upfront total thyroidectomy (TTx), diagnostic lobectomy for Bethesda I-I...

ea0086p243 | Neuroendocrinology and Pituitary | SFEBES2022

Imaging surveillance of completely resected gastroenteropancreatic neuroendocrine tumors is associated with high levels of radiation exposure

Ianuzzi Jordan , Yeo Caitlin , Parkins Vicky , Pasieka Janice , Ruether Dean , Chan Denise , Albalawi Zaina , Stewart Errol , Lithgow Kirstie

Background & Aims: Neuroendocrine tumours (NET) are a heterogenous group of neoplasms that secrete peptides and neuroamines. For potentially malignant gastroenteropancreatic (GEP) NET, surgical resection represents the only curative option. Ten-year imaging surveillance programs using cross sectional imaging are recommended due to long time-to-recurrence following resection. We performed a retrospective chart review to evaluate radiation exposure associated with surveillan...